HS
NVO

Horan Securities’s Novo Nordisk NVO Stock Holding History

Horan Securities’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-254
Closed -$20.5K – 464
2023
Q2 		$20.5K Hold
254
– – 0.01% 316
2023
Q1 		$20.2K Sell
254
-152
-37% -$10.8K 0.01% 303
2022
Q4 		$27.4K Hold
406
– – 0.02% 264
2022
Q3 		$20K Buy
406
+2
+0.5% +$107 0.01% 268
2022
Q2 		$23K Buy
404
+2
+0.5% +$111 0.01% 249
2022
Q1 		$22K Hold
402
– – 0.01% 244
2021
Q4 		$22K Buy
+402
New +$21.8K 0.01% 236

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Horan Securities's NVO Position: Q3 2023 in Review

Horan Securities sold out of Novo Nordisk (NVO) in Q3 2023, closing a stake of 254 shares — an estimated $20.5K sold.

Horan Securities first reported a position in NVO in Q4 2021 and held it in 7 quarters. The position peaked at $27.4K in Q4 2022. 1,307 funds tracked by Wall St. Rank hold NVO as of Q3 2023.

  • Horan Securities reported no remaining Novo Nordisk position as of Q3 2023 after selling out during the quarter.
  • Horan Securities sold 254 Novo Nordisk shares in Q3 2023, an estimated $20.5K.
  • Horan Securities first reported a position in Novo Nordisk in Q4 2021 and held it in 7 quarters.
  • Horan Securities's Novo Nordisk position peaked at $27.4K in Q4 2022.
  • 1,307 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2023.

Based on Horan Securities's 13F filing for Q3 2023, filed 1 Nov 2023.